Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
BridgeBio Pharma Inc banner

BridgeBio Pharma Inc
XBER:2CL

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
XBER:2CL
Watchlist
Price: 0.057 EUR Market Closed
Market Cap: €8.4m
Write Note Create Alert Ask AI

Wall St Price Targets

2CL Price Targets Summary
BridgeBio Pharma Inc

Wall Street analysts forecast 2CL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 2CL is 0.071 EUR with a low forecast of 0.054 EUR and a high forecast of 0.111 EUR.

2CL Lowest Forecast
0.054 EUR
-5% Downside
2CL Average Forecast
0.071 EUR
25% Upside
2CL Highest Forecast
0.111 EUR
94% Upside
Lowest Forecast
Price Target
0.054 EUR
5% Downside
Average Forecast
Price Target
0.071 EUR
25% Upside
Highest Forecast
Price Target
0.111 EUR
94% Upside
BridgeBio Pharma Inc Competitors:
Price Targets
NFLX
Netflix Inc
67% Upside
KRNY
Kearny Financial Corp
6% Upside
CIGI
Colliers International Group Inc
14% Upside
CREX
Creative Realities Inc
167% Upside
NFLX
Netflix Inc
67% Upside
KRNY
Kearny Financial Corp
6% Upside
CIGI
Colliers International Group Inc
14% Upside
CREX
Creative Realities Inc
167% Upside
ZEAL
Zealand Pharma A/S
71% Upside

Revenue
Forecast

N/A
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

The compound annual growth rate for Revenue over the next 8 years is 37%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss
N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-14%
Average Miss

The compound annual growth rate for Gross Profit over the next 8 years is 36%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

What are analyst estimates?

Continue 2CL Research

Summary
2CL intrinsic value, competitors valuation, and company profile.
DCF Valuation
2CL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
2CL stock valuation using valuation multiples.
Wall St Estimates
2CL price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
2CL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other BridgeBio Pharma Inc listings:
NASDAQ • USD
BBIO
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 2CL's stock price target?
Price Target
0.071 EUR

According to Wall Street analysts, the average 1-year price target for 2CL is 0.071 EUR with a low forecast of 0.054 EUR and a high forecast of 0.111 EUR.

What is the Revenue forecast for BridgeBio Pharma Inc?
Projected CAGR
37%

The compound annual growth rate for Revenue over the next 8 years is 37%.

What is the Gross Profit forecast for BridgeBio Pharma Inc?
Projected CAGR
36%

The compound annual growth rate for Gross Profit over the next 8 years is 36%.

Back to Top
ALPHA SPREAD
Follow us
Join 349,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett